Learn / CTNM
NASDAQ: CTNM
Contineum Therapeutics (CTNM) stock, explained like you're 5
Contineum Therapeutics trades on the Nasdaq under the ticker CTNM. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 503 million dollars.
- Ticker
- CTNM
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 503 million dollars
Is Contineum Therapeutics a small, medium or large cap company?
No. Contineum Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 503 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Contineum Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CTNM stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Baird Downgrades Contineum Therapeutics to Neutral From Outperform, Price Target is $14 (Yahoo Finance)
- (CTNM) Volatility Zones as Tactical Triggers (Stock Traders Daily)
- Why Is Contineum Therapeutics Stock Falling Monday? (Benzinga)
- $CTNM stock is down 29% today. Here's what we see in our data. (Quiver Quantitative)
- Baird downgrades Contineum Therapeutics stock on IPF trial data (Investing.com)
Follow CTNM in your daily brief
Each trading day at 5 PM ET we post what happened to Contineum Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CTNM
Questions about Contineum Therapeutics stock
What does Contineum Therapeutics do?
Contineum Therapeutics trades on the Nasdaq under the ticker CTNM. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 503 million dollars.
What is the ticker symbol for Contineum Therapeutics?
Contineum Therapeutics trades under the ticker CTNM on the Nasdaq.
What is Contineum Therapeutics's market cap?
Contineum Therapeutics is a small cap stock with a market cap of about 503 million dollars.
How does Contineum Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CTNM stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CTNM stock every day?
Add CTNM to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.